General Information
Compass MDD 006
A Phase III, multicentre, randomised, double-blind, controlled study to investigate the efficacy, safety, and tolerability of two administrations of COMP360 in participants with treatment-resistant depression
| Protocol | Compass 006 |
|---|---|
| Identifier | |
| UID | 67459c2b-8568-4821-bfb7-d94b05ff8b0d |
| Status | Follow-up |
| Phase | 3 |
| Category | Major Depressive Disorder / Adult |
| Launch Year | 0 |
| NCT Number | - |
| Created | 2023-09-13 17:05 |
| Last Updated | 2025-08-06 19:11 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2025-08-06 | No |
| Enrollment Open | 2023-08-31 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2023-06-19 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | No | |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Volk, Stephen | SVolk | No |
| Recruiter | Gomez, Kathie | KGomez | No |
| Coordinator | Sandoval, Larry | LSandoval | No |
| Regulatory | Ramirez, Claudia | CRamirez | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | COMPASS Pathfinder Limited |
|---|---|
| Division | COMPASS Pathfinder Limited |
| Team | COMPASS Pathfinder Limited |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | ICON |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | PaleGoldenrod |
| Currency | - |
